Sonja Sachse
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sonja Sachse has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Azadeh Izadifar
VIB Center for Brain and Disease Research, Leuven, Belgium
2 shared publications- Dietmar Schmucker
VIB Center for Brain and Disease Research, Herestraat 49, Leuven 3000, Belgium; KU Leuven Department of Neuroscience, Herestraat 49, Leuven 3000, Belgium; Neuronal Wiring Group, Life & Medical Sciences Institute, University of Bonn, Carl-Troll-Straße 31, Bonn D53115, Germany; Leuven Brain Institute, Herestraat 49, Leuven 3000, Belgium
2 shared publications - Olivier Urwyler
Institute of Cell Biology, University of Bern, Bern, Switzerland
2 shared publications Yoshiaki Kise
VIB Center for Brain & Disease Research, Leuven, Belgium
2 shared publicationsAnke Misbaer
VIB Center for Brain & Disease Research, Leuven, Belgium
1 shared publication- Anke Misbaer
Discovery Biology, MUNA Therapeutics, Heverlee Belgium
1 shared publication
Latest Publications
- 3 May 2019
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 364 (6439) , 454-+
Branch-restricted localization of phosphatase Prl-1 specifies axonal synaptogenesis domains
Compartmentalization of axons: Neurons can spread branches far and wide across the central nervous system. One neuron can simultaneously contact several other neurons, amplifying network complexity. Studying the Drosophila brain, Urwyler et al. found that not all axon branches are the same, even within one neuron (see the Perspective by Falkner and Scheiffele). A membrane-anchored phosphatase functions within a subset of axon branches to regulate synapse formation. Thus, the pattern of synapses on one neuron is not random but rather is spatially restricted according to subcompartments in the axon. Science , this issue p. eaau9952 ; see also p. 437
- 3 May 2019
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 364 (6439) , 454-+
Branch-restricted localization of phosphatase Prl-1 specifies axonal synaptogenesis domains
Compartmentalization of axons: Neurons can spread branches far and wide across the central nervous system. One neuron can simultaneously contact several other neurons, amplifying network complexity. Studying the Drosophila brain, Urwyler et al. found that not all axon branches are the same, even within one neuron (see the Perspective by Falkner and Scheiffele). A membrane-anchored phosphatase functions within a subset of axon branches to regulate synapse formation. Thus, the pattern of synapses on one neuron is not random but rather is spatially restricted according to subcompartments in the axon. Science , this issue p. eaau9952 ; see also p. 437
- 11 February 2019
- Published by Springer Nature in The EMBO Journal
- Vol. 38 (6) , e99669
Nuclear import of the DSCAM‐cytoplasmic domain drives signaling capable of inhibiting synapse formation
DSCAM and DSCAML1 are immunoglobulin and cell adhesion‐type receptors serving important neurodevelopmental functions including control of axon growth, branching, neurite self‐avoidance, and neuronal cell death. The signal transduction mechanisms or effectors of DSCAM receptors, however, remain poorly characterized. We used a human ORFeome library to perform a high‐throughput screen in mammalian cells and identified novel cytoplasmic signaling effector candidates including the Down syndrome kinase Dyrk1a, STAT3, USP21, and SH2D2A. Unexpectedly, we also found that the intracellular domains (ICDs) of DSCAM and DSCAML1 specifically and directly interact with IPO5, a nuclear import protein of the importin beta family, via a conserved nuclear localization signal. The DSCAM ICD is released by γ‐secretase‐dependent cleavage, and both the DSCAM and DSCAML1 ICDs efficiently translocate to the nucleus. Furthermore, RNA sequencing confirms that expression of the DSCAM as well as the DSCAML1 ICDs alone can profoundly alter the expression of genes associated with neuronal differentiation and apoptosis, as well as synapse formation and function. Gain‐of‐function experiments using primary cortical neurons show that increasing the levels of either the DSCAM or the DSCAML1 ICD leads to an impairment of neurite growth. Strikingly, increased expression of either full‐length DSCAM or the DSCAM ICD, but not the DSCAML1 ICD, significantly decreases synapse numbers in primary hippocampal neurons. Taken together, we identified a novel membrane‐to‐nucleus signaling mechanism by which DSCAM receptors can alter the expression of regulators of neuronal differentiation and synapse formation and function. Considering that chromosomal duplications lead to increased DSCAM expression in trisomy 21, our findings may help uncover novel mechanisms contributing to intellectual disability in Down syndrome. Synopsis A novel membrane‐to‐nucleus signaling mechanism of DSCAMs affects the expression of neuronal target genes. Nuclear enrichment of the cleaved intracellular domain of DSCAM (DSCAM‐ICD) in developing neurons can lead to an impairment of neurite growth and strong decrease of synapse numbers. The DYRK family kinases DYRK1A and DYRK1B, the SH2‐domain adaptor SH2D2A, the Ubiquitin specific peptidase USP21, and the transcription factor STAT3 are novel cytoplasmic binding partners of DSCAM and DSCAML1. The ICDs of DSCAM and DSCAML1 interact with the importin beta IPO5 via a conserved nuclear localization signal. γ‐secretase mediated intra‐membrane cleavage of DSCAM results in the release of the DSCAM ICD and both the DSCAM and DSCAML1 ICDs efficiently translocate to the nucleus. In the nucleus, the DSCAM ICD alters the transcription of several genes involved in neuronal differentiation and synapse formation.
- 11 February 2019
- Published by Springer Nature in The EMBO Journal
- Vol. 38 (6) , e99669
Nuclear import of the DSCAM‐cytoplasmic domain drives signaling capable of inhibiting synapse formation
DSCAM and DSCAML1 are immunoglobulin and cell adhesion‐type receptors serving important neurodevelopmental functions including control of axon growth, branching, neurite self‐avoidance, and neuronal cell death. The signal transduction mechanisms or effectors of DSCAM receptors, however, remain poorly characterized. We used a human ORFeome library to perform a high‐throughput screen in mammalian cells and identified novel cytoplasmic signaling effector candidates including the Down syndrome kinase Dyrk1a, STAT3, USP21, and SH2D2A. Unexpectedly, we also found that the intracellular domains (ICDs) of DSCAM and DSCAML1 specifically and directly interact with IPO5, a nuclear import protein of the importin beta family, via a conserved nuclear localization signal. The DSCAM ICD is released by γ‐secretase‐dependent cleavage, and both the DSCAM and DSCAML1 ICDs efficiently translocate to the nucleus. Furthermore, RNA sequencing confirms that expression of the DSCAM as well as the DSCAML1 ICDs alone can profoundly alter the expression of genes associated with neuronal differentiation and apoptosis, as well as synapse formation and function. Gain‐of‐function experiments using primary cortical neurons show that increasing the levels of either the DSCAM or the DSCAML1 ICD leads to an impairment of neurite growth. Strikingly, increased expression of either full‐length DSCAM or the DSCAM ICD, but not the DSCAML1 ICD, significantly decreases synapse numbers in primary hippocampal neurons. Taken together, we identified a novel membrane‐to‐nucleus signaling mechanism by which DSCAM receptors can alter the expression of regulators of neuronal differentiation and synapse formation and function. Considering that chromosomal duplications lead to increased DSCAM expression in trisomy 21, our findings may help uncover novel mechanisms contributing to intellectual disability in Down syndrome. Synopsis A novel membrane‐to‐nucleus signaling mechanism of DSCAMs affects the expression of neuronal target genes. Nuclear enrichment of the cleaved intracellular domain of DSCAM (DSCAM‐ICD) in developing neurons can lead to an impairment of neurite growth and strong decrease of synapse numbers. The DYRK family kinases DYRK1A and DYRK1B, the SH2‐domain adaptor SH2D2A, the Ubiquitin specific peptidase USP21, and the transcription factor STAT3 are novel cytoplasmic binding partners of DSCAM and DSCAML1. The ICDs of DSCAM and DSCAML1 interact with the importin beta IPO5 via a conserved nuclear localization signal. γ‐secretase mediated intra‐membrane cleavage of DSCAM results in the release of the DSCAM ICD and both the DSCAM and DSCAML1 ICDs efficiently translocate to the nucleus. In the nucleus, the DSCAM ICD alters the transcription of several genes involved in neuronal differentiation and synapse formation.